| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/13/2023 | 268.66% | Benchmark | $8 → $8 | Maintains | Buy |
| 08/15/2023 | 61.29% | B. Riley Securities | $4.5 → $3.5 | Maintains | Neutral |
| 08/15/2023 | 268.66% | Benchmark | → $8 | Reiterates | Buy → Buy |
| 06/28/2023 | 107.37% | B. Riley Securities | $5.5 → $4.5 | Maintains | Neutral |
| 08/16/2022 | 268.66% | Benchmark | $11 → $8 | Maintains | Buy |
| 06/15/2022 | 199.54% | B. Riley Securities | $9 → $6.5 | Downgrades | Buy → Neutral |
| 05/25/2022 | 314.75% | B. Riley Securities | $10 → $9 | Maintains | Buy |
| 07/27/2021 | 406.91% | Benchmark | → $11 | Initiates Coverage On | → Buy |
| 05/27/2021 | 360.83% | Loop Capital | → $10 | Initiates Coverage On | → Buy |
| 08/28/2020 | 268.66% | Craig-Hallum | → $8 | Initiates Coverage On | → Buy |
What is the target price for Transphorm (TGAN)?
The latest price target for Transphorm (NASDAQ: TGAN) was reported by Benchmark on October 13, 2023. The analyst firm set a price target for $8.00 expecting TGAN to rise to within 12 months (a possible 268.66% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Transphorm (TGAN)?
The latest analyst rating for Transphorm (NASDAQ: TGAN) was provided by Benchmark, and Transphorm maintained their buy rating.
When is the next analyst rating going to be posted or updated for Transphorm (TGAN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Transphorm, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Transphorm was filed on October 13, 2023 so you should expect the next rating to be made available sometime around October 13, 2024.
Is the Analyst Rating Transphorm (TGAN) correct?
While ratings are subjective and will change, the latest Transphorm (TGAN) rating was a maintained with a price target of $8.00 to $8.00. The current price Transphorm (TGAN) is trading at is $2.17, which is out of the analyst's predicted range.